JR Holding has invested in the British biotechnology company Nanovery

JR Holding ASI (JRH) has invested PLN 250 thousand. GBP (approx. PLN 1.33 million) in Nanovery, a biotechnology company based in Newcastle, UK, in exchange for 143,678 shares representing 10.13% of the capital, as part of an investment round for a total of GBP 1.85 million, the company announced.

“At the same time, JRH joined, with the consent of the existing shareholders, an investment agreement binding the company’s shareholders. Nanovery has created a technological platform for detecting trace amounts of DNA and RNA strands circulating in complex biological samples. The result will be a simple test that can be combined with a sample (such as blood, serum, plasma) that provides precise measurement of ultra-low levels of these biomarkers. The way it works and the format of the assay mean that it can be integrated into standard laboratory procedures using equipment that is already in place.

JR Holding participated in a £1.85m investment round involving the North East Innovation Fund supported by the European Regional Development Fund and managed by Northstar Ventures, Prostate Cancer Research and business angels, while Innovate UK, the UK’s national innovation agency, awarded the company a grant of 750,000. GBP to develop screening activities, also stated.

“The £1.85m raised will support our efforts to save more lives through better prostate cancer testing. While mortality rates for other cancers are improving, the opposite is true for prostate cancer. With our technology, we can provide cheap, simple tests that are highly accurate. We are glad that JR Holding, a leading Polish investment company, joins the British investors and institutions supporting us, enabling us to intensify our development work,” said the president and founder of Nanovera, Dr. Jerzy Kozyra, quoted in the release.


“We are proud to present our next investment in the biotechnology sector. It is a globally innovative company based in Great Britain, whose founder is a Polish scientist. This is our next international investment. Such companies, developing breakthrough technologies, are our main investment goals. When we say that we want to support projects that will change the future of their industries, we do not throw words to the wind,” said investor and president of JR Holding, January Ciszewski.

JR Holding ASI S.A. is a company listed on the NewConnect market since 2012, focusing on investment activities and involvement in companies from the following industries: digital business, renewable energy sources, computer games, medical, biotechnology and modern media. In accordance with the strategy, this year the company intends to develop the portfolio by increasing its diversification, investing in the most promising ventures and launching new investment projects. The company is on its way to debut on the main market of the Warsaw Stock Exchange.


Our privacy policy